Iovance Biotherapeutics Inc. (NASDAQ:IOVA) is one of the best biotech penny stocks to buy according to analysts. On December 17, Barclays analyst Etzer Darout raised the firm’s price target on Iovance Biotherapeutics to $10 from $9, while keeping an Overweight rating on the shares. This announcement was made as part of the firm’s 2026 projections, where it revised its valuation targets for the biotech industry. Earlier in Q3 2025, Iovance Biotherapeutics Inc. (NASDAQ:IOVA) highlighted a total product rev ...

Crude Value Insights offers you an investing service and community focused on oil and natural gas. We focus on cash flow and the companies that generate it, leading to value and growth prospects with real potential.Subscribers get to use a 50+ stock model account, in-depth cash flow analyses of E&P firms, and live chat discussion of the sector.Sign up today for your two-week free trial and get a new lease on oil & gas! ...

Kanzhun operates China’s largest online recruitment marketplace, and rising profits are attracting new institutional interest, with CoreView Capital's stake now valued at more than $220 million. What happenedAccording to a filing with the Securities and Exchange Commission dated November 13, 2025, CoreView Capital Management Ltd bought 298,584 additional shares of Kanzhun Limited (BZ 0.39%). The post-trade position totals 9,447,889 shares, valued at $220.70 million as of September 30, 2025. This action brou ...

Key Takeaways NDSN's Medical and Fluid Solutions organic sales rose 7.4% year over year in Q4 fiscal 2025.Nordson improved segment EBITDA margins through higher sales, footprint optimization and cost reductions.The Atrion acquisition expanded Nordson's medical offerings in infusion and cardiovascular therapies.Nordson Corporation (NDSN) is witnessing solid momentum in the Medical and Fluid Solutions segment, organic sales from which increased 7.4% year over year in the fourth quarter of fiscal 2025 (ended O ...

Key Takeaways AI-driven demand powered a strong 2025 for chips, with momentum expected to extend into 2026, lifting NVIDIA.Global chip sales hit $208.4B in Q3 2025, up 15.8% sequentially, supporting Analog Devices.SEMI forecasts chip equipment sales at $133B in 2025, rising to $145B in 2026 and $156B in 2027 for MTSI.The semiconductor market had a remarkable year, with more room to grow in 2026, thanks to robust demand from various industries and the ongoing enthusiasm surrounding artificial intelligence (A ...

In October, money expert Sam Dogen wrote a CNBC article about the strategies he used to retire at 34. An investment banker in California’s Bay Area at the time, he quit his job with $80,000 a year in passive income and a $3 million net worth. Dogen built his assets for a decade before retiring and has continued to live off passive income. He shared these seven investment opportunities that he appreciates for their passive income potential. 1. Dividend Stocks Owning dividend stocks means you own shares ...

The exercise-and-sell transaction came as the rare disease drugmaker reported strong quarterly results. Jeffrey Del Carmen, Chief Commercial Officer of Catalyst Pharmaceuticals (CPRX +0.26%), exercised and immediately sold 10,983 shares of common stock on November 26, 2025, for a total value of approximately $256,200, as disclosed in this SEC Form 4 filing.Transaction summaryMetricValueShares sold10,983Transaction value~$256,200Post-transaction shares3,962Post-transaction value (direct ownership)~$92,800Tra ...

Philadelphia, Pennsylvania--(Newsfile Corp. - December 31, 2025) - National plaintiffs' law firm Berger Montague PC announces that a class action lawsuit has been filed against Klarna Group plc (NYSE: KLAR) ("Klarna" or the "Company") on behalf of investors who purchased or otherwise acquired Klarna securities during the period of September 7, 2025 through December 22, 2025 (the "Class Period"), including shares issued pursuant and/or traceable to Klarna's September 2025 initial public offering ("IPO").Inv ...

Key Points Costco outperformed the S&P 500 over the last 10 years by a wide margin. Much of the stock's previous 10-year return was due to an increase in the price-to-earnings multiple. 10 stocks we like better than Costco Wholesale › Costco Wholesale (NASDAQ: COST) has been a rewarding investment for investors. It would have made early investors millionaires, but even if you had bought the stock in 2015, you would still be outperforming the S&P 500. A $1,000 investment in Costco stock 10 years ag ...

Company announcement – No. 27 / 2025 Total number of shares and voting rights in Zealand Pharma as of December 31, 2025 Copenhagen, Denmark, December 31, 2025 – Zealand Pharma A/S ("the Company" or “Zealand Pharma”) (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology company transforming the future of metabolic health, today announces, in accordance with section 32 of the Danish Capital Markets Act, the total number of shares and voting rights in the Company at the end of a calendar month during which change ...